SFEE oncology platform
#WeWontRest until everyone diagnosed with cancer has a brighter future
Tackling the challenges of Europe’s second biggest cause of death requires collaboration, partnership and novel approaches. That is the goal of the SFEE oncology platform which brings together SFEE member companies aiming to transform the lives of patients diagnosed with cancer.
Although more people are being diagnosed with cancer, deaths from cancer are slowing down and survival rates are improving.
New therapies, along with advances in prevention, screening, radiotherapy and surgery, are saving lives every day. The number of lung cancer patients that are alive one year after diagnosis is more than ten times higher than in 1995, when only five out of 100 lung cancer patients were alive after one year. For patients, it means more moments with family, friends and children. It means more moments to enjoy life.
The speed of medical innovation for cancer patients is unprecedented. Increasingly, therapy selection in oncology is tailored to the individual patient and disease characteristics, to improve the likelihood of patients responding to treatment. The body’s own immune system can be activated to attack the tumor. And gene and cell-based therapies provide a potential cure.
We will continue to invest in research and development to search for new ways to beat cancer and #WeWontRest until every patient in Greece can have access to innovation in cancer care.
